Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615251 · ClinicalTrials.gov registry record · Phase 3
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
A Phase 3 study of Infertility, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,297
- Enrollment target
- 20
- Study locations
NCT00615251: Completed Phase 3 study of Infertility, sponsored by Duramed Research.
NCT00615251 is a Phase 3 study of Infertility that has completed, run by Duramed Research. The registered enrollment target is 1,297 participants, below the 7,572-participant average among 74 other Infertility trials with a reported enrollment target (83% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00615251, a Phase 3 study of Infertility, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,297 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a multi-center study to evaluate the effects of DR-2011 compared to a progesterone gel in women undergoing in vitro fertilization with fresh eggs. The overall study duration will be approximately 12 months and will involve ovarian suppression/stimulation protocols as well as egg retrieval.
Conditions Studied
Interventions
- DRUG DR-2011
- DRUG Crinone 8%
Study Locations (20)
Michigan
- Duramed Investigational Site - Dearborn
- Duramed Investigational Site - Flint
- Duramed Investigational Site - Rochester Hills
- Duramed Investigational Site - Saginaw
- Duramed Investigational Site - Ypsilanti
California
- Duramed Investigational Site - Tarzana
- Duramed Investigational Site - West Los Angeles
- Duramed Investigational Site - Westlake
Georgia
- Duramed Investigational Site - Alpharetta
- Duramed Investigational Site - Atlanta
Illinois
- Duramed Investigational Site - Chicago
- Duramed Investigational Site - Highland Park
New Jersey
- Duramed Investigational Site - Marlton
- Duramed Investigational Site - Morristown
Florida
- Duramed Investigational Site - Clearwater
Idaho
- Duramed Investigational Site - Boise
Maryland
- Duramed Investigational Site - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,297 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 3 |
What the finished NCT00615251 record still lists
NCT00615251 is an interventional study that assigns participants to a tested intervention. Its 1,297 participants enrollment target places it among the larger protocols in the corpus, below the 7,572-participant average among 74 other Infertility trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which DR-2011 is the first listed.
NCT00615251 names 20 study sites across 11 states, led by Michigan, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT00615251 about?
NCT00615251 is a clinical study titled "A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization". This is a multi-center study to evaluate the effects of DR-2011 compared to a progesterone gel in women undergoing in vitro fertilization with fresh eggs. The overall study duration will be approximately 12 months and will involve ovarian suppression/stimulation protocols as well as egg retrieval.
What is the current status of trial NCT00615251?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,297 participants. The study started on 2008-02. Estimated completion is 2009-08.
What conditions does trial NCT00615251 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT00615251?
The interventions under investigation include: DR-2011 (DRUG), Crinone 8% (DRUG).
Who is sponsoring clinical trial NCT00615251?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00615251 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00615251's enrollment target sits among peer trials
1,297 13th of 74 higher than 62 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
RECRUITING · Phase 3
-
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
RECRUITING · Phase 3
-
Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
ACTIVE NOT RECRUITING · Phase 3
-
Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation
COMPLETED · Phase 3
-
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
COMPLETED · Phase 3
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia